SCHEMBL770799

SCHEMBL770799

O=C(NCCC(=O)N1CCCC2CCCCC21)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 6/20 0.60
SMN1; SMN2 Q16637 3/20 0.55
HSD11B1 P28845 3/20 0.55
HSD17B1 P14061 1/20 0.55
RAB9A P51151 2/20 0.52
NPC1 O15118 1/20 0.52
PREP P48147 2/20 0.52
FAP Q12884 1/20 0.52
DPP7 Q9UHL4 1/20 0.50
KDM4E B2RXH2 1/20 0.48
HTT P42858 1/20 0.48
ALDH1A1 P00352 1/20 0.48
GAA P10253 1/20 0.48
KMT2A Q03164 1/20 0.47
CHRM1 P11229 2/20 0.47
ACE P12821 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL772292 0.93 DPP4 (0.70) DPP4SMN1; SMN2HSD11B1HSD17B1RAB9A
SCHEMBL770259 0.83 HSD11B1 (0.59) DPP4SMN1; SMN2HSD11B1HSD17B1RAB9A
SCHEMBL770221 0.83 NPC1 (0.63) DPP4SMN1; SMN2HSD11B1HSD17B1RAB9A
SCHEMBL771679 0.83 NPC1 (0.47) DPP4SMN1; SMN2HSD11B1HSD17B1RAB9A
SCHEMBL771367 0.82 PREP (0.55) DPP4SMN1; SMN2HSD11B1RAB9ANPC1
SCHEMBL770428 0.82 DPP4 (0.49) DPP4SMN1; SMN2HSD11B1RAB9ANPC1
SCHEMBL771034 0.82 PREP (0.59) PREP
SCHEMBL770258 0.82 PREP (0.57) SMN1; SMN2RAB9ANPC1PREPFAP
SCHEMBL772325 0.81 RAB9A (0.53) SMN1; SMN2RAB9ANPC1ALDH1A1ACE
SCHEMBL770967 0.81 RAB9A (0.56) SMN1; SMN2RAB9ANPC1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2439202-B1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 SALVAT LAB SA (ES) 2016-04-20 EP disclosed
US-8822452-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2014-09-02 US disclosed
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-8524894-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2013-09-03 US disclosed
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2012-03-22 US disclosed
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 DPP4 1092/4885SMN1; SMN2 3653/4885HSD11B1 1/4885
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 DPP4 1125/4885SMN1; SMN2 3637/4885HSD11B1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.